Cover Image
市場調查報告書

基因編輯:技術和全球市場

Genome Editing: Technologies and Global Markets

出版商 BCC Research 商品編碼 355580
出版日期 內容資訊 英文 129 Pages
訂單完成後即時交付
價格
Back to Top
基因編輯:技術和全球市場 Genome Editing: Technologies and Global Markets
出版日期: 2016年03月31日 內容資訊: 英文 129 Pages
簡介

全球基因編輯市場2014年達2億600萬美元,2015年達3億9,500萬美元規模。該市場今後到2020年預計以年複合成長率38.9%擴大,超越20億美元。

本報告提供全球基因編輯的概要與規模,各地區、產業、用途、產品、技術、終端用戶趨勢,及主要加入企業簡介彙整。

第1章 簡介

第2章 市場摘要

  • 市場成長的主要的推動因素

第3章 目前基因編輯技術

第4章 基因編輯的用途

  • 簡介
  • 學術研究
  • 藥物研發、開發
  • 臨床
  • 非基因改造育種
  • 其他

第5章 市場區隔與預測

  • 市場概要
  • 主要企業
  • 各地區市場市場區隔
  • 各用途市場市場區隔
  • 各技術市場區隔
  • 各產品市場區隔

第6章 受託服務市場分析

第7章 研究市場分析

第8章 藥物開發市場分析

第9章 農業生物科技市場分析

第10章 臨床市場分析

第11章 競爭環境與機會

  • 概要
  • 成長策略
  • 機會

第12章 基因編輯影響市場的因素

  • 簡介
  • 推動力
  • 限制市場成長的因素

第13章 企業簡介

圖表

目錄
Product Code: BIO146A

REPORT HIGHLIGHTS

The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.

This report provides:

  • An overview of the global markets and technologies for genome editing, a promising new approach that can overcome the shortcomings from site-directed mutagenesis and recombination based methods using relatively simple concepts.
  • Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • A focus on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products.
  • Breakdowns of the market by region, industry, application, product and type, technology, and end-user.
  • A look at the recent technical breakthrough on the use of CRISPR/Cas9 and how it has fueled the rapid growth of the genome editing industry.
  • A look at other growth driving factors including: the need of precision medicine for accurate genome editing technology; the increased R&D expenditure in related industrial sectors (e.g. biopharma, agriculture, and energy); increased funding for genomics research and its technological advancements; increasing demand for synthetic genes in synthetic biology; Concerns that genetically modified crops can be reduced by applying gene editing technologies to non-trangenic plant breeding.
  • Exploration of emerging ethical issues.
  • A relevant patent analysis.
  • Profiles of key players in the industry.

SCOPE OF REPORT

This study is focused on the market side of genome editing, along with a comprehensive review of genome editing technologies with related latest progresses in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and Rest of World.

Specifically, centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as its each segment. It details recent technical breakthroughs as well as major technical issues to overcome before the genome editing is applied to clinic applications. The growth driving factors and the factors that may limit the market's growth are identified. The ethical issues, regulatory issues and intellectual property right issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

ANALYST'S CREDENTIALS

Mike Fan is a certified life science product and marketing management professional. His more than 20 years of experience cover multiple biotech R&D areas as well as life science marketing in both academia and industry. Mike has a broad range of technical skills in chemical and biological areas. He holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - MARKET SUMMARY

  • KEY DRIVERS FOR MARKET GROWTH
    • SUMMARY TABLE: GLOBAL GENOME EDITING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • SUMMARY FIGURE: GLOBAL GENOME EDITING MARKET BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - CURRENT GENOME EDITING TECHNOLOGIES

  • OVERVIEW
  • HISTORY OF GENOME EDITING
  • COMPARISON OF GENOME EDITORS
  • DISCOVERY OF CRISPR/CAS9
  • COMPONENTS OF CRISPR/CAS SYSTEMS
    • SGRNA
    • CAS9 NUCLEASES
  • HOW CRISPR/CAS WORKS
  • ADVANTAGES OF THE CRISPR/CAS9 SYSTEM
  • POPULARITY OF CRISPR GENOME EDITING
  • MAJOR TECHNOLOGICAL ISSUES
    • EFFICIENCY
    • SPECIFICITY/OFF-TARGET EFFECT
    • DELIVERY SYSTEMS
      • Viral Delivery Systems
      • Non-Viral Delivery Systems
      • Physical Delivery Systems
  • A NEW GENOME EDITING SYSTEM: CRISPR-CPF1
  • STUDIES ON TREATING DISEASES USING GENOME EDITING
  • IMPACTS OF GENOME EDITING
  • FUTURE OF CRISPR

CHAPTER 4 - APPLICATIONS OF GENOME EDITING

  • INTRODUCTION
  • ACADEMIC RESEARCH
  • DRUG DISCOVERY AND DEVELOPMENT
  • CLINICAL THERAPY
  • NON-TRANSGENIC BREEDING
  • OTHER APPLICATIONS

CHAPTER 5 - MARKET SEGMENTATION AND FORECAST

  • MARKET OVERVIEW
  • MAJOR PLAYERS
    • TABLE 1: MAJOR COMPANIES THAT HAVE BUSINESS RELATED TO GENOME EDITING
    • TABLE 2: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY REGION, AS OF JANUARY 2016
    • FIGURE 1: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY REGION, AS OF JANUARY 2016 (%)
    • TABLE 3: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY STATE IN THE U.S., AS OF JANUARY 2016 (NUMBER/%)
  • MARKET SEGMENTS BY REGION
    • TABLE 4: GLOBAL MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 2: GLOBAL MARKET FOR GENOME EDITING BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 3: GLOBAL GENOME EDITING MARKET SHARE BY REGION, 2014 (%)
    • FIGURE 4: GLOBAL GENOME EDITING MARKET SHARE BY REGION, 2020 (%)
  • MARKET SEGMENTS BY APPLICATION
    • TABLE 5: GLOBAL MARKETS FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 5: GLOBAL MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 6: GLOBAL MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • TABLE 6: U.S. MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 7: U.S. MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 8: U.S. MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • TABLE 7: EUROPEAN MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 9: EUROPEAN MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 10: EUROPEAN MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • TABLE 8: ASIA-PACIFIC MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 11: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 12: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • TABLE 9: REST OF WORLD MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
  • MARKET SEGMENTS BY TECHNOLOGY
    • TABLE 10: GLOBAL MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 13: GLOBAL MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 14: GLOBAL MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • TABLE 11: U.S. MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 15: U.S. MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 16: U.S. MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • TABLE 12: EUROPEAN MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 17: EUROPEAN MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 18: EUROPEAN MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • TABLE 13: ASIA-PACIFIC MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 19: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 20: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • TABLE 14: REST OF WORLD MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • MARKET SEGMENTS BY PRODUCT TYPE
    • TABLE 15: GLOBAL MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • FIGURE 21: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT TYPE, 2014 (%)
    • FIGURE 22: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT TYPE, 2020 (%)
    • TABLE 16: U.S. MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: EUROPEAN MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: ASIA-PACIFIC MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: REST OF WORLD MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - CONTRACT SERVICES MARKET ANALYSIS

  • MARKET OVERVIEW
  • MAJOR PLAYERS
    • TABLE 20: MAJOR COMPANIES THAT PROVIDE GENOME EDITING RELATED SERVICES, AS OF JANUARY 31, 2016
  • MARKET SHARE AND PROJECTION
    • TABLE 21: GLOBAL MARKET FOR GENOME EDITING SERVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 23: GLOBAL MARKET SHARES FOR GENOME EDITING SERVICES BY REGION, 2014 (%)
    • FIGURE 24: GLOBAL MARKET SHARES FOR GENOME EDITING SERVICES BY REGION, 2020 (%)
  • COMPARISON WITH PRODUCT SEGMENT
    • TABLE 22: GLOBAL MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • FIGURE 25: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT AND SERVICE, 2014 (%)
    • FIGURE 26: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT AND SERVICE, 2020 (%)
    • TABLE 23: U.S. MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: EUROPEAN MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: ASIA-PACIFIC MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: REST OF WORLD MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - RESEARCH MARKET ANALYSIS

  • MARKET OVERVIEW
  • MARKER SHARE AND PROJECTIONS
    • TABLE 27: GLOBAL ACADEMIC RESEARCH MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 27: GLOBAL ACADEMIC RESEARCH MARKET SHARES FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 28: GLOBAL ACADEMIC RESEARCH MARKET SHARES FOR GENOME EDITING BY REGION, 2020 (%)
  • PATENT ANALYSIS
    • TABLE 28: DISTRIBUTION OF GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY COUNTRY (NUMBER/%)
    • TABLE 29: DISTRIBUTION OF U.S. GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY STATE (NUMBER/%)
    • TABLE 30: DISTRIBUTION OF GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY PATENT OFFICE (NUMBER/%)
    • TABLE 31: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY YEAR, 2007-2015
    • TABLE 32: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY YEAR, 2007-2015
    • TABLE 33: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY TECHNOLOGY, 2007-2015 (NUMBER/%)
    • FIGURE 29: GENOME EDITING PATENTS AND PATENT APPLICATIONS BY TECHNOLOGY, 2007-2015 (%)
  • PUBLICATION ANALYSIS
    • FIGURE 30: NUMBER OF CRISPR PUBLICATIONS BY YEAR, 2005-2015
    • FIGURE 31: NUMBER OF ZFNS PUBLICATIONS BY YEAR, 2005-2015
    • FIGURE 32: NUMBER OF TALENS PUBLICATIONS BY YEAR, 2011-2015
  • RESEARCH FUNDING ANALYSIS
    • TABLE 34: NIH FUNDING FOR GENE/GENOME EDITING BY YEAR, 2007-2015 ($ MILLIONS)
    • FIGURE 33: NIH FUNDING FOR GENE/GENOME EDITING BY YEAR, 2007-2015 ($ MILLIONS)
    • TABLE 35: NIH-FUNDED RESEARCH GRANTS BY YEAR, 2007-2015 ($ MILLIONS)
    • FIGURE 34: NIH-FUNDED RESEARCH GRANTS BY YEAR, 2007-2015 ($ MILLIONS)

CHAPTER 8 - DRUG DEVELOPMENT MARKET ANALYSIS

  • MARKET OVERVIEW
  • MARKET SHARE AND FORECAST
    • TABLE 36: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 35: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 36: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, 2020 (%)

CHAPTER 9 - AGRICULTURAL BIOTECHNOLOGY MARKET ANALYSIS

  • MARKET OVERVIEW
  • MARKET SHARE AND FORECAST
    • TABLE 37: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 37: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 38: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, 2020 (%)

CHAPTER 10 - CLINICAL MARKET ANALYSIS

  • MARKET OVERVIEW
  • MARKET SHARE AND FORECAST
    • FIGURE 39: GLOBAL CLINIC GENOME EDITING MARKET BY REGION, 2020 (%)
  • COMPARISON WITH NON-CLINICAL MARKET
    • TABLE 38: GLOBAL MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • FIGURE 40: GLOBAL MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, 2020 (%)
    • TABLE 39: U.S. MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: EUROPEAN MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: ASIA-PACIFIC MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: REST OF WORLD MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)

CHAPTER 11 - COMPETITION LANDSCAPE AND OPPORTUNITIES

  • OVERVIEW
  • GROWTH STRATEGIES
    • LICENSING AND AGREEMENTS
    • COLLABORATIONS WITH BIG BIOPHARMACEUTICAL COMPANIES
    • IN-HOUSE R&D PROGRAM
    • STARTUP
    • STRATEGIC ALLIANCE AND JOINT VENTURE
    • FOCUS ON SPECIFIC APPLICATION AREAS
    • VENTURE CAPITAL FUNDING
  • OPPORTUNITIES

CHAPTER 12 - FACTORS INFLUENCING THE GENOME EDITING MARKET

  • INTRODUCTION
  • DRIVING FORCES
    • NEW GENOME EDITING TECHNOLOGIES AND RELATED ADVANCEMENTS
    • NEW APPLICATIONS OF GENOME EDITING
    • NEED OF PRECISION MEDICINE
    • NEED OF IMPROVING DRUG DISCOVERY PROCESS
    • INCREASING DEMAND FOR SYNTHETIC GENES IN SYNTHETIC BIOLOGY
    • INVESTMENTS FROM BOTH PUBLIC AND PRIVATE SECTORS
    • INCREASED R&D EXPENDITURES IN RELATED INDUSTRIAL SECTORS
    • HIGH PREVALENCE OF GENETIC BIRTH DISORDERS
    • CONCERNS ON GENETICALLY MODIFIED CROPS
  • FACTORS LIMITING THE MARKET'S GROWTH
    • STRINGENT REGULATORY FRAMEWORKS AND TIME-CONSUMING APPROVAL PROCESSES
    • RESEARCH FUNDING
    • PATENT DISPUTE
    • GOVERNMENTAL POLICIES AND REGULATIONS
    • REGULATORY UNCERTAINTY ON GENOME EDITED CROPS
    • ETHICAL ISSUE

CHAPTER 13 - COMPANY PROFILES

  • ADDGENE
  • AGILENT TECHNOLOGIES INC.
  • APPLIED STEMCELL INC.
  • ASTRA ZENECA
  • CALYXT
  • CARIBOU BIOSCIENCES
  • CELLECTA INC.
  • CELLECTIS S.A.
  • CIBUS
  • CLONTECH LABORATORIES
  • CRISPR THERAPEUTICS
  • DESKTOP GENETICS
  • DNA2.0
  • EDITAS MEDICINE
  • GE HEALTHCARE DHARMACON
  • GENECOPOEIA
  • GENSCRIPT
  • HORIZON DISCOVERY
  • INNOVATIVE GENOMICS INITIATIVE
  • INTELLIA THERAPEUTICS INC.
  • INTEGRATED DNA TECHNOLOGIES
  • IXCELLS BIOTECHNOLOGIES
  • JUNO THERAPEUTICS
  • LONZA
  • NEW ENGLAND BIOLABS
  • NOVA SYNTHETIX
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES INC.
  • RECOMBINETICS
  • REGENERON PHARMACEUTALS INC.
  • SANGAMO BIOSCIENCES
  • SIGMA-ALDRICH CORP.
  • SYSTEM BIOSCIENCES
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
  • TRANS GENIC INC.
  • TRANSOMIC TECHNOLOGIES INC.
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL GENOME EDITING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: MAJOR COMPANIES THAT HAVE BUSINESS RELATED TO GENOME EDITING
    • TABLE 2: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY REGION, AS OF JANUARY 2016
    • TABLE 3: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY STATE IN THE U.S., AS OF JANUARY 2016 (NUMBER/%)
    • TABLE 4: GLOBAL MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKETS FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 6: U.S. MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 7: EUROPEAN MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: ASIA-PACIFIC MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: REST OF WORLD MARKET FOR GENOME EDITING BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: U.S. MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: EUROPEAN MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: ASIA-PACIFIC MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: REST OF WORLD MARKET FOR GENOME EDITING BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: U.S. MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: EUROPEAN MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: ASIA-PACIFIC MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: REST OF WORLD MARKET FOR GENOME EDITING BY PRODUCT TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: MAJOR COMPANIES THAT PROVIDE GENOME EDITING RELATED SERVICES, AS OF JANUARY 31, 2016
    • TABLE 21: GLOBAL MARKET FOR GENOME EDITING SERVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: U.S. MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: EUROPEAN MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: ASIA-PACIFIC MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: REST OF WORLD MARKET FOR GENOME EDITING BY PRODUCT AND SERVICE, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GLOBAL ACADEMIC RESEARCH MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: DISTRIBUTION OF GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY COUNTRY (NUMBER/%)
    • TABLE 29: DISTRIBUTION OF U.S. GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY STATE (NUMBER/%)
    • TABLE 30: DISTRIBUTION OF GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY PATENT OFFICE (NUMBER/%)
    • TABLE 31: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY YEAR, 2007-2015
    • TABLE 32: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT WIPO BY YEAR, 2007-2015
    • TABLE 33: GENOME EDITING PATENTS AND PATENT APPLICATIONS AT USPTO BY TECHNOLOGY, 2007-2015 (NUMBER/%)
    • TABLE 34: NIH FUNDING FOR GENE/GENOME EDITING BY YEAR, 2007-2015 ($ MILLIONS)
    • TABLE 35: NIH-FUNDED RESEARCH GRANTS BY YEAR, 2007-2015 ($ MILLIONS)
    • TABLE 36: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: U.S. MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: EUROPEAN MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: ASIA-PACIFIC MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: REST OF WORLD MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, THROUGH 2020 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL GENOME EDITING MARKET BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: DISTRIBUTION OF COMPANIES THAT HAVE GENOME EDITING RELATED BUSINESSES BY REGION, AS OF JANUARY 2016 (%)
    • FIGURE 2: GLOBAL MARKET FOR GENOME EDITING BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 3: GLOBAL GENOME EDITING MARKET SHARE BY REGION, 2014 (%)
    • FIGURE 4: GLOBAL GENOME EDITING MARKET SHARE BY REGION, 2020 (%)
    • FIGURE 5: GLOBAL MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 6: GLOBAL MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • FIGURE 7: U.S. MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 8: U.S. MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • FIGURE 9: EUROPEAN MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 10: EUROPEAN MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • FIGURE 11: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2014 (%)
    • FIGURE 12: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY APPLICATION, 2020 (%)
    • FIGURE 13: GLOBAL MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 14: GLOBAL MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • FIGURE 15: U.S. MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 16: U.S. MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • FIGURE 17: EUROPEAN MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 18: EUROPEAN MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • FIGURE 19: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2014 (%)
    • FIGURE 20: ASIA-PACIFIC MARKET SHARES FOR GENOME EDITING BY TECHNOLOGY, 2020 (%)
    • FIGURE 21: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT TYPE, 2014 (%)
    • FIGURE 22: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT TYPE, 2020 (%)
    • FIGURE 23: GLOBAL MARKET SHARES FOR GENOME EDITING SERVICES BY REGION, 2014 (%)
    • FIGURE 24: GLOBAL MARKET SHARES FOR GENOME EDITING SERVICES BY REGION, 2020 (%)
    • FIGURE 25: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT AND SERVICE, 2014 (%)
    • FIGURE 26: GLOBAL MARKET SHARES FOR GENOME EDITING BY PRODUCT AND SERVICE, 2020 (%)
    • FIGURE 27: GLOBAL ACADEMIC RESEARCH MARKET SHARES FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 28: GLOBAL ACADEMIC RESEARCH MARKET SHARES FOR GENOME EDITING BY REGION, 2020 (%)
    • FIGURE 29: GENOME EDITING PATENTS AND PATENT APPLICATIONS BY TECHNOLOGY, 2007-2015 (%)
    • FIGURE 30: NUMBER OF CRISPR PUBLICATIONS BY YEAR, 2005-2015
    • FIGURE 31: NUMBER OF ZFNS PUBLICATIONS BY YEAR, 2005-2015
    • FIGURE 32: NUMBER OF TALENS PUBLICATIONS BY YEAR, 2011-2015
    • FIGURE 33: NIH FUNDING FOR GENE/GENOME EDITING BY YEAR, 2007-2015 ($ MILLIONS)
    • FIGURE 34: NIH-FUNDED RESEARCH GRANTS BY YEAR, 2007-2015 ($ MILLIONS)
    • FIGURE 35: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 36: GLOBAL DRUG DEVELOPMENT MARKET FOR GENOME EDITING BY REGION, 2020 (%)
    • FIGURE 37: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, 2014 (%)
    • FIGURE 38: GLOBAL PLANT BREEDING MARKET FOR GENOME EDITING BY REGION, 2020 (%)
    • FIGURE 39: GLOBAL CLINIC GENOME EDITING MARKET BY REGION, 2020 (%)
    • FIGURE 40: GLOBAL MARKET FOR GENOME EDITING BY CLINICAL PRODUCT AND NON-CLINICAL PRODUCT, 2020 (%)
Back to Top